| Literature DB >> 28135311 |
Xin Zhang1,2,3, Yinnan Mu1,2,3, Pengfei Mu2,3, Jingqun Ao2,3, Xinhua Chen2,3,4.
Abstract
Vaccination is an effective and safe strategy for combating bacterial diseases in fish, but the mechanisms underlying the early immune response after vaccination remain to be elucidated. In the present study, we used RNA-seq technology to perform transcriptome analysis of spleens from large yellow croaker (Larimichthys crocea) induced by inactivated trivalent bacterial vaccine (Vibrio parahaemolyticus, Vibrio alginolyticus and Aeromonas hydrophila). A total of 2,789 or 1,511 differentially expressed genes (DEGs) were obtained at 24 or 72 h after vaccination, including 1,132 or 842 remarkably up-regulated genes and 1,657 or 669 remarkably down-regulated genes, respectively. Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichments revealed that numerous DEGs belong to immune-relevant genes, involved in many immune-relevant pathways. Most of the strongly up-regulated DEGs are innate defense molecules, such as antimicrobial peptides, complement components, lectins, and transferrins. Trivalent bacterial vaccine affected the expressions of many components associated with bacterial ligand-depending Toll-like receptor signaling pathways and inflammasome formation, indicating that multiple innate immune processes were activated at the early period of vaccination in large yellow croaker. Moreover, the expression levels of genes involved in antigen processing were also up-regulated by bacterial vaccine. However, the expression levels of several T cell receptors and related CD molecules and signal transducers were down-regulated, suggesting that the T cell receptor signaling pathway was rapidly suppressed after vaccination. These results provide the comprehensive insights into the early immune response of large yellow croaker to vaccination and valuable information for developing a highly immunogenic vaccine against bacterial infection in teleosts.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28135311 PMCID: PMC5279777 DOI: 10.1371/journal.pone.0170958
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the data for transcriptomes.
| Sample | Insert size (bp) | Read length (bp) | Number of clean reads | Clean bases (bp) | Alignment togenome (%) | Alignment to CDS (%) |
|---|---|---|---|---|---|---|
| 0 h | 200 | 90_90 | 63,568,408 | 5,721,156,720 | 70.57 | 41.42 |
| 24 h | 200 | 90_90 | 60,346,074 | 5,431,146,660 | 71.41 | 42.03 |
| 72 h | 200 | 90_90 | 60,445,278 | 5,440,075,020 | 70.54 | 41.49 |
Immune-relevant KEGG pathways.
| Pathway ID | Pathway name | Number of all | Number of DEGs (24 h) | Number of DEGs (72 h) |
|---|---|---|---|---|
| ko04020 | Calcium signaling pathway | 120 | 21 | 5 |
| ko04514 | Cell adhesion molecules (CAMs) | 75 | 18 | 6 |
| ko04060 | Cytokine-cytokine receptor interaction | 73 | 17 | 8 |
| ko04142 | Lysosome | 69 | 16 | 4 |
| ko04010 | MAPK signaling pathway | 110 | 16 | 6 |
| ko04145 | Phagosome | 101 | 15 | 7 |
| ko04144 | Endocytosis | 133 | 15 | 9 |
| ko04064 | NF-kappa B signaling pathway | 64 | 14 | 4 |
| ko04670 | Leukocyte transendothelial migration | 84 | 14 | 3 |
| ko04062 | Chemokine signaling pathway | 80 | 11 | 4 |
| ko04666 | Fc gamma R-mediated phagocytosis | 82 | 11 | 4 |
| ko04660 | T cell receptor signaling pathway | 61 | 10 | 4 |
| ko04650 | Natural killer cell mediated cytotoxicity | 50 | 9 | 2 |
| ko04612 | Antigen processing and presentation | 25 | 8 | 4 |
| ko04120 | Ubiquitin mediated proteolysis | 65 | 8 | 4 |
*: Be based on each relevant KEGG pathway.
Immune-relevant DEGs found in the trivalent vaccine-induced transcriptome.
| Accession number | Description | Gene name | log2ratio (24 h/0 h) | log2ratio (72 h/0 h) | ||
|---|---|---|---|---|---|---|
| Complement and coagulation cascades | ||||||
| EH28_12969 | Complement component 2 | C2 | -0.05 | 4.02E-01 | 1.03 | 3.83E-71 |
| EH28_04156 | Complement component 3 | C3 | 1.64 | 0.00E+00 | -0.07 | 0.00E+00 |
| EH28_10105 | Complement component 7 | C7 | 3.38 | 4.54E-148 | 1.57 | 3.93E-18 |
| EH28_10318 | Complement factor B | BF | 2.26 | 2.58E-08 | 1.67 | 2.39E-04 |
| EH28_11857 | Complement factor D | DF | 1.19 | 0.00E+00 | 0.97 | 4.00E-308 |
| EH28_04424 | Complement factor H | HF | 0.24 | 1.02E-76 | 1.25 | 1.22E-108 |
| EH28_00866 | Coagulation factor VII | F7 | 1.37 | 2.64E-01 | 2.24 | 3.10E-02 |
| EH28_13616 | Coagulation factor VIII | F8 | 2.73 | 0.00E+00 | 2.29 | 0.00E+00 |
| EH28_04699 | Thrombospondin-1 | THBS1 | 3.28 | 0.00E+00 | 0.46 | 2.46E-04 |
| Lectins | ||||||
| EH28_17226 | C-type lectin domain family 4 member E | CLEC4E | 3.07 | 6.05E-169 | 1.98 | 4.42E-48 |
| EH28_19458 | C-type lectin domain family 17 member A | CLEC17A | 0.69 | 3.39E-04 | 1.07 | 2.40E-09 |
| EH28_17225 | Collectin-12 | COLEC12 | 6.56 | 5.78E-79 | 4.26 | 5.85E-14 |
| EH28_00227 | Fucolectin-1 | F-lectin 1 | -0.78 | 1.13E-06 | 1.67 | 2.17E-53 |
| EH28_08704 | Fucolectin-5 | F-lectin 5 | -0.82 | 2.00E-02 | 1.02 | 8.22E-05 |
| EH28_17496 | Pentraxin-related protein PTX3 | PTX3 | 3.19 | 1.03E-09 | 1.9 | 4.52E-03 |
| EH28_05767 | Pentraxin-4 | PTX4 | 4.50 | 4.21E-195 | 3.34 | 3.45E-70 |
| Antibacterial proteins | ||||||
| EH28_24821 | Bactericidal permeability-increasing protein | BPI | 0.49 | 1.33E-18 | 1.32 | 1.7E-167 |
| EH28_14666 | Haptoglobin | HP | 4.36 | 0.00E+00 | 1.79 | 1.86E-35 |
| EH28_06996 | Hepcidin-1 | Hep-1 | 3.34 | 1.10E-57 | 1.02 | 1.89E-03 |
| EH28_15797 | Lysozyme g | LysG | 1.43 | 4.28E-31 | 1.34 | 3.20E-26 |
| EH28_25262 | Serotransferrin | TF | 6.79 | 4.37E-92 | 4.9 | 8.76E-23 |
| Pattern recognition receptors | ||||||
| EH28_23426 | C-type lectin receptor | CTLR | 2.12 | 4.13E-26 | 0.82 | 1.30E-03 |
| EH28_21627 | Macrophage mannose receptor 1 | MMR1 | 1.17 | 8.80E-112 | 1.26 | 1.02E-132 |
| EH28_00392 | NACHT, LRR and PYD domains containing protein 1 | NLRP1 | 1.09 | 4.42E-02 | 0.47 | 5.78E-02 |
| EH28_22777 | NACHT, LRR and PYD domains containing protein 3 | NLRP3 | 1.71 | 3.70E-37 | 1.42 | 3.70E-37 |
| EH28_21234 | Peptidoglycan-recognition protein SC2 | PGRP-SC2 | 15.68 | 6.27E-33 | 13.46 | 1E-07 |
| EH28_09444 | Toll-like receptor 3 | TLR3 | -3.05 | 1.98E-81 | -1.95 | 1.39E-48 |
| EH28_18671 | Toll-like receptor 5 | TLR5M | 3.71 | 1.07E-46 | 1.54 | 8.47E-08 |
| Adaptor and signal transducers | ||||||
| EH28_14997 | Apoptosis-associated speck-like protein containing a CARD | ASC | 1.10 | 5.17E-26 | 0.59 | 4.81E-07 |
| EH28_25086 | Mitogen-activated protein kinase 15 | ERK | 1.74 | 2.59E-08 | 0.62 | 1.05E-01 |
| EH28_14297 | NF-kappa-B inhibitor alpha | IκBα | 1.90 | 0.00E+00 | 0.34 | 9.45E-11 |
| EH28_20652 | Putative ATP-dependent RNA helicase DHX58 | LGP-2 | -1.09 | 9.02E-89 | -0.35 | 2.80E-13 |
| EH28_12674 | Rho guanine nucleotide exchange factor 12 | LARG | 1.61 | 7.84E-61 | 0.51 | 2.00E-05 |
| EH28_06883 | Transcription factor AP-1 | Ap-1 | 2.13 | 7.56E-89 | 0.12 | 4.53E-01 |
| Cytokines | ||||||
| EH28_13993 | C-C motif chemokine 4 | CCL4 | 2.46 | 2.86E-87 | 2.52 | 1.91E-92 |
| EH28_23981 | C-C motif chemokine 19 | CCL19 | 2.64 | 0.00E+00 | 0.77 | 5.43E-54 |
| EH28_25343 | C-C motif chemokine 20 | CCL20 | 3.71 | 5.25E-09 | 1.33 | 1.95E-01 |
| EH28_21923 | Interleukin-1 beta | IL-1β | 5.16 | 5.92E-91 | 3.3 | 3.22E-19 |
| EH28_25178 | Interleukin-6 | IL-6 | 5.19 | 1.09E-37 | 2.41 | 5.79E-04 |
| EH28_18941 | Interleukin-10 | IL-10 | 4.14 | 1.73E-14 | 3.02 | 5.09E-24 |
| EH28_23359 | Interleukin-12 subunit beta | IL-12 | 3.64 | 1.55E-28 | 0.43 | 4.72E-01 |
| EH28_14432 | Interleukin-27 subunit beta | IL-27 | 1.80 | 1.67E-15 | 1.19 | 2.61E-06 |
| EH28_03825 | Interleukin-34 | IL-34 | 1.03 | 1.39E-06 | 1.06 | 6.59E-07 |
| EH28_07798 | Interferon gamma | IFN-γ | 1.65 | 2.82E-04 | 1.93 | 8.9E-06 |
| EH28_05037 | Tumor necrosis factor alpha | TNF-α | 2.07 | 5.97E-04 | 0.50 | 5.39E-01 |
| Cytokine receptors | ||||||
| EH28_03117 | C-X-C chemokine receptor type 1 | CXCR1 | 1.92 | 1.33E-226 | 0.64 | 2.45E-17 |
| EH28_21430 | C-X-C chemokine receptor type 3 | CXCR3 | 1.19 | 6.26E-47 | 0.55 | 3.52E-09 |
| EH28_18535 | Interleukin-1 receptor type 2 | IL-1R | 7.32 | 0.00E+00 | 4.62 | 3.18E-99 |
| EH28_07447 | Interleukin-12 receptor subunit beta-2 | IL-12R | 1.26 | 8.92E-122 | 0.27 | 4.40E-05 |
| EH28_04343 | Interleukin-22 receptor subunit alpha-2 | IL-22R | 1.65 | 8.52E-05 | 0.19 | 7.50E-01 |
| EH28_19418 | Apoptosis facilitator Bcl-2-like protein 14 | BCL2L14 | 1.97 | 1.60E-34 | 1.55 | 4.60E-19 |
| EH28_07897 | Apoptosis regulator BAX | BAX | 1.04 | 5.90E-05 | 1.22 | 1.05E-06 |
| EH28_10711 | B-cell lymphoma 6 protein | BCL6 | 1.27 | 1.39E-31 | 0.45 | 3.09E-04 |
| EH28_18771 | Caspase-8 | CASP8 | 1.13 | 2.03E-24 | 0.53 | 2.58E-05 |
| EH28_18769 | Caspase-10 | CASP10 | 1.07 | 2.91E-22 | 1.02 | 5.27E-20 |
| EH28_19874 | Antigen peptide transporter 1 | TAP1 | 2.38 | 0.00E-00 | 1.21 | 5.21E-80 |
| EH28_06369 | Antigen peptide transporter 2 | TAP2 | 1.28 | 1.66E-71 | 0.90 | 1.21E-31 |
| EH28_09011 | Calreticulin | CLAR | 1.53 | 1.60E-01 | 1.47 | 2.12E-178 |
| EH28_06817 | Cathepsin L | CTSL | 1.23 | 1.24E-168 | 1.12 | 1.03E-131 |
| EH28_11008 | Cathepsin O | CTSO | 1.10 | 3.35E-07 | 0.67 | 4.33E-03 |
| EH28_11216 | Endoplasmic reticulum aminopeptidase 1 | ERAP1 | 1.32 | 6.11E-86 | 0.86 | 6.17E-32 |
| EH28_24090 | Endoplasmic reticulum aminopeptidase 2 | ERAP2 | 1.76 | 1.99E-92 | 0.90 | 3.73E-19 |
| EH28_14158 | Heat shock protein 70KDa-4 | HSP70 | 1.35 | 1.61E-47 | 0.83 | 4.94E-16 |
| EH28_21169 | HLA class II histocompatibility antigen gamma chain | MHC- II | -0.19 | 1.42E-36 | -0.71 | 0.00E+00 |
| EH28_17090 | Lysosome-associated membrane glycoprotein 1 | LAMP-1 | 2.08 | 0.00E+00 | 1.13 | 8.36E-100 |
| EH28_25045 | Lysosomal thioesterase PPT2-A | PPT2 | 1.53 | 1.00E-05 | 0.74 | 7.00E-02 |
| EH28_00289 | Major histocompatibility complex, class I | MHC-I | 0.75 | 2.09E-299 | 0.32 | 3.49E-125 |
| EH28_18380 | Proteasome activator subunit 1 | PA28α | 1.11 | 9.93E-113 | 1.12 | 1.05E-114 |
| EH28_02969 | Proteasome activator complex subunit 2 | PA28β | 1.55 | 2.06E-202 | 1.2 | 5.77E-106 |
| EH28_21964 | Proteasome subunit alpha type-1 | PSMA1 | 1.24 | 6.62E-118 | 1.18 | 9.09E-105 |
| EH28_21059 | Proteasome subunit alpha type-4 | PSMA4 | 1.25 | 1.15E-66 | 1.37 | 1.01E-82 |
| EH28_10635 | Proteasome subunit beta type-2 | PSMB2 | 1.28 | 1.22E-69 | 1.37 | 2.58E-82 |
| EH28_20274 | Proteasome subunit beta type-7 | PSMB7 | 1.38 | 1.19E-82 | 0.95 | 7.43E-34 |
| EH28_19428 | Tapasin | TAPBP | 1.06 | 1.35E-39 | 0.38 | 2.62E-09 |
| EH28_05511 | CD3 gamma chain | CD3γ | -1.20 | 2.01E-12 | -0.41 | 3.65E-03 |
| EH28_19424 | Protein kinase C theta type | PKCθ | -0.92 | 6.35E-10 | -0.34 | 1.01E-02 |
| EH28_04099 | Pyruvate dehydrogenase kinase isozyme 2 | PDK | -1.52 | 2.24E-118 | -1.33 | 5.55E-97 |
| EH28_02274 | T-cell receptor alpha chain V region | TCRα | -1.28 | 6.49E-05 | -0.66 | 2.06E-02 |
| EH28_23685 | T-cell receptor beta chain T17T-22 | TCRβ | -1.18 | 1.13E-23 | 0.02 | 9.01E-01 |
| EH28_17224 | T-cell surface glycoprotein CD4 | CD4 | -1.85 | 2.66E-42 | -0.31 | 2.35E-03 |
| EH28_09327 | T-cell surface glycoprotein CD8 beta chain | CD8β | -1.70 | 1.38E-02 | -1.00 | 9.95E-02 |
| EH28_16421 | Tyrosine-protein kinase Fyn | FYN | -1.07 | 9.37E-25 | -0.71 | 2.86E-13 |
| EH28_09736 | Tyrosine-protein kinase ZAP-70 | ZAP-70 | -1.44 | 2.35E-09 | 0.18 | 3.62E-01 |
| EH28_23772 | 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | PLC-y1 | -1.33 | 8.40E-40 | -0.62 | 2.70E-12 |